Skip to content
DataLookout
Menu

HEATNCT07226310

The Hysterosalpingogram (HSG) Experience And Tubal Spasm (HEAT) Study

StatusRecruiting
PhaseEarly Phase 1
Primary completion (estimated)

At risk: Primary completion moved at least 9 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Dec 2026 to Oct 2027
    • Eligibility criteria expanded, about 10 words
    • Start date changed from estimate of Sep 2026 to Aug 12, 2026
    • Secondary endpoints: details revised at 1 of 1 entry
  2. Notable Start date: May 2026 to Sep 2026v5
  3. Notable Start date: Mar 2026 to May 2026v4
  4. Minor Start date: Feb 2026 to Mar 2026
    • Study description shortened, about 70 words
    v3
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Dec 2025 to Feb 2026
    • Site details revised
    v2
  6. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Post-HSG Pain Questionnaire
Timeframe: Measured 1 hour after HSG procedure

Secondary (1)

Rate of unilateral and bilateral proximal fallopian tube occlusion

Arms and interventions

Cold HSGNo intervention

HSG contrast will be standard, room-temperature

Warm HSGActive comparator

HSG constrast will be warmed.

Drugs: Warmed HSG

Sites

1 site in 1 country

  • University of Oklahoma Health CenterOklahoma City, Oklahoma, United States